Atlas One · Host Biology · Scale 03 — Molecular

VHL

VHL tumor suppressor targets HIF-1α for proteasomal degradation under normoxia; VHL loss → constitutive HIF activation → VEGF, PDGF, and EPO. Biallelic VHL inactivation causes clear cell RCC (~75%) and von Hippel-Lindau syndrome (hemangioblastomas, pheochromocytoma).

Also known as: VHL, von Hippel-Lindau, VHL tumor suppressor, HIF regulation, E3 ubiquitin ligase, clear cell RCC, von Hippel-Lindau disease, VBC complex

Scale 03 — MolecularScale
draftStatus
2026-06-06Last Reviewed
This is an auto-generated stub page built from atlas entry frontmatter. A richer hand-crafted page is planned. See the atlas source for the full entry including detailed body sections.
vhl

VHL

VHL tumor suppressor targets HIF-1α for proteasomal degradation under normoxia; VHL loss → constitutive HIF activation → VEGF, PDGF, and EPO. Biallelic VHL inactivation causes clear cell RCC (~75%) and von Hippel-Lindau syndrome (hemangioblastomas, pheochromocytoma).